Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Prins

Showing results (41-50 of 560) with videos related to

Pageof 56
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Potential implications of COVID-19 in non-alcoholic fatty liver diseaseGrietje H Prins, Peter Olinga
The American Journal of Cardiology|January 25, 1991
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarctionM H Prins, J Hirsh
Thrombosis and Haemostasis|December 28, 1990
A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical reviewM H Prins, J Hirsh
Journal of Clinical Epidemiology|September 5, 2003
When do we need what evidence?Martin H Prins, Harry R Büller
The Cochrane Database of Systematic Reviews|September 9, 2010
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolismPetra Mg Erkens, Martin H Prins
Seminars in Vascular Medicine|June 17, 2004
Fibrin D-dimer measurement in suspected pulmonary embolismP de Moerloose, M H Prins
Thrombosis and Haemostasis|December 29, 1999
Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?A W Lensing, M H Prins
Haemostasis|March 17, 2001
Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?P M Bossuyt, M H Prins
Haemostasis|May 7, 2002
Venous thromboembolism and occult malignancy: an historical perspectiveH M Otten, M H Prins
Methods of Information in Medicine|December 11, 2007
Requirements analysis of information services for patients on a general practitioner's website--patient and general practitioner's perspectivesA H Prins, A Abu-Hanna
Pageof 56

Showing results (41-50 of 560) with videos related to

Sort By:
Pageof 56
Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Potential implications of COVID-19 in non-alcoholic fatty liver diseaseGrietje H Prins, Peter Olinga
The American Journal of Cardiology|January 25, 1991
Heparin as an adjunctive treatment after thrombolytic therapy for acute myocardial infarctionM H Prins, J Hirsh
Thrombosis and Haemostasis|December 28, 1990
A comparison of general anesthesia and regional anesthesia as a risk factor for deep vein thrombosis following hip surgery: a critical reviewM H Prins, J Hirsh
Journal of Clinical Epidemiology|September 5, 2003
When do we need what evidence?Martin H Prins, Harry R Büller
The Cochrane Database of Systematic Reviews|September 9, 2010
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolismPetra Mg Erkens, Martin H Prins
Seminars in Vascular Medicine|June 17, 2004
Fibrin D-dimer measurement in suspected pulmonary embolismP de Moerloose, M H Prins
Thrombosis and Haemostasis|December 29, 1999
Recurrent deep vein thrombosis and two coagulation factor gene mutations: quo vadis?A W Lensing, M H Prins
Haemostasis|March 17, 2001
Does low-molecular-weight heparin reduce the costs of venous thromboembolism treatment?P M Bossuyt, M H Prins
Haemostasis|May 7, 2002
Venous thromboembolism and occult malignancy: an historical perspectiveH M Otten, M H Prins
Methods of Information in Medicine|December 11, 2007
Requirements analysis of information services for patients on a general practitioner's website--patient and general practitioner's perspectivesA H Prins, A Abu-Hanna
Pageof 56